Clinical Trial – Reduction of Intrapartum Fever With Intravenous Acetaminophen – Fever

The investigators plan to administer acetaminophen (Tylenol) for the treatment of fever in laboring patients by either an oral or intravenous (IV) route. The investigators want to see if the maternal fever will decrease faster with the IV or the oral dose. The investigators also want to look at other outcomes such as the cesarean section rate, the rate of neonatal intensive care unit admissions in both groups.

 

Study Type: Interventional  (Clinical Trial)
Estimated Enrollment: 168 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Care Provider, Investigator)
Primary Purpose: Treatment
Official Title: Randomized Control Trial of Intravenous Acetaminophen (OFIRMEV) for the Reduction of Intrapartum Maternal Feverrrr and Fetal Tachycardia
Actual Study Start Date: December 2016
Estimated Primary Completion Date: July 2018
Estimated Study Completion Date: July 2018

 

Contact

Contact: Nisha Lakhi, MD 7188182109 nlakhi@yahoo.com
Contact: Michael Moretti, MD 7188182109 Mmoretti@rumcsi.org

 

ClinicalTrials.gov Identifier: NCT02625454

 

For enrollment please visit www.clinicaltrials.gov.

Leave a Reply